NCT02468830View on ClinicalTrials.gov

Pilot Study of Mirabegron in Pediatric Patients With Overactive Bladder

PHASE3CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

March 31, 2016

Conditions
Overactive BladderUrinary Incontinence
Interventions
DRUG

mirabegron

Switch treatment from antimuscarinic to study medication. A dose up-titration will be possible if well tolerated and sub-optimal efficacy.

All Listed Sponsors
lead

CHU de Quebec-Universite Laval

OTHER

NCT02468830 - Pilot Study of Mirabegron in Pediatric Patients With Overactive Bladder | Biotech Hunter | Biotech Hunter